Erectile Dysfunction in Patients with Reheumatological Diseases

Erectile Dysfunction in Patients with Reheumatological Diseases

Erectile dysfunction (ED) in patients with rheumatological diseases presents a complex interplay between the physiological manifestations of the condition and its psychological ramifications. Rheumatological diseases, encompassing a spectrum of disorders such as rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis, often involve chronic inflammation and autoimmune processes that can affect multiple systems within the body, including vascular, neurological, and endocrine functions.


ED in patients with rheumatological diseases are multifactorial, stemming from both the physiological effects of the underlying condition and the psychosocial impact of living with a chronic disease. Here are some key factors contributing to ED in this population:

  • Vascular Dysfunction: Rheumatological diseases like rheumatoid arthritis and systemic lupus erythematosus can lead to inflammation and damage to blood vessels, impairing blood flow to the genital area. Poor vascular health is a common cause of ED.
  • Neurological Complications: Some rheumatological conditions, such as ankylosing spondylitis, can affect the nervous system, leading to neuropathies or nerve damage. Nerve dysfunction plays a crucial role in achieving and maintaining erections.
  • Hormonal Imbalance: Endocrine disturbances are prevalent in certain rheumatological diseases, including disruptions in testosterone levels. Testosterone is essential for libido and erectile function, and alterations in its levels can contribute to ED.
  • Medications: Many medications used to manage rheumatological diseases, such as corticosteroids and immunosuppressants, can have adverse effects on sexual function. These drugs may interfere with hormone levels or have direct effects on vascular health and nerve function.
  • Psychological Factors: Living with a chronic rheumatological disease can lead to psychological stress, anxiety, depression, and body image issues, all of which are known contributors to ED. The psychological burden of the disease can exacerbate sexual dysfunction.
  • Physical Limitations: Pain, stiffness, fatigue, and physical limitations associated with rheumatological diseases can affect sexual desire and performance. These symptoms may lead to decreased sexual activity and intimacy, further exacerbating ED.
  • Systemic Inflammation: Chronic inflammation, which is a hallmark of many rheumatological diseases, can contribute to endothelial dysfunction and atherosclerosis, further compromising vascular health and contributing to ED.
  • Coexisting Health Conditions: Patients with rheumatological diseases often have other comorbidities such as diabetes, hypertension, and obesity, which are additional risk factors for ED.


ED in patients with rheumatological diseases involves a comprehensive evaluation that considers both the physical and psychological aspects of the condition. Here’s an overview of the diagnostic process:

  • Medical History: Urologist will begin by taking a detailed medical history, including information about the patient’s rheumatological disease, its severity, duration, and treatments. They will also inquire about the onset and duration of ED symptoms, any precipitating factors, and the presence of other medical conditions or medications that could contribute to ED.
  • Physical Examination: A thorough physical examination will be conducted to assess for signs of rheumatological disease activity, such as joint swelling, deformities, or skin manifestations. Additionally, the healthcare provider may perform a genital examination to evaluate for any anatomical abnormalities or signs of vascular or neurological dysfunction.
  • Laboratory Tests: Laboratory tests may be ordered to assess for underlying medical conditions that could contribute to ED, such as diabetes, hypertension, hyperlipidemia, or hormonal imbalances. Specific tests may include blood glucose levels, lipid profile, hormone levels (including testosterone), and markers of inflammation.
  • Imaging Studies: In some cases, imaging studies such as Doppler ultrasonography may be performed to evaluate penile blood flow and detect any abnormalities in the vascular system that could be causing or contributing to ED.
  • Psychological Evaluation: Given the significant psychological impact of living with a chronic rheumatological disease, a psychological evaluation may be warranted to assess for the presence of mood disorders (such as depression or anxiety), stressors, relationship issues, or other psychosocial factors that could be contributing to ED.
  • Questionnaires: Various validated questionnaires, such as the International Index of Erectile Function (IIEF), may be used to assess the severity of ED symptoms, evaluate the impact on quality of life, and monitor treatment outcomes over time.
  • Collaborative Approach: Diagnosis and management of ED in patients with rheumatological diseases often require a multidisciplinary approach involving rheumatologists, urologists, endocrinologists, and mental health professionals. Collaboration among these specialists is essential to address the complex interplay of physiological and psychological factors contributing to ED in this population.


Treating ED in patients with rheumatological diseases requires a comprehensive approach that addresses both the underlying rheumatological condition and the specific factors contributing to ED. Here are some treatment options commonly considered:

Management of Underlying Rheumatological Disease:

  • Optimizing the treatment of the rheumatological disease itself can often improve erectile function. This may involve medications such as disease-modifying antirheumatic drugs (DMARDs), biologic agents, corticosteroids, or nonsteroidal anti-inflammatory drugs (NSAIDs), tailored to the individual patient’s needs.
    • Physical therapy, exercise, and lifestyle modifications may also play a role in managing symptoms and improving overall health.

Medications for Erectile Dysfunction:

  • Oral phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra) are commonly prescribed as first-line treatments for ED. These medications work by enhancing the effects of nitric oxide, leading to increased blood flow to the penis.
    • In patients with rheumatological diseases who are taking nitrates or alpha-blockers for cardiovascular conditions, PDE5 inhibitors may be contraindicated due to potential interactions. Alternative treatments should be considered in such cases.

Intraurethral Suppositories or Penile Injections:

  • Alprostadil, a prostaglandin E1 analogue, can be administered as an intraurethral suppository (MUSE) or injected directly into the penis (intracavernosal injections) to stimulate penile blood flow and induce an erection.

Vacuum Erection Devices (VEDs):

  • VEDs are non-invasive devices that use negative pressure to draw blood into the penis, resulting in an erection. They may be used alone or in combination with other treatments for ED.

Hormone Replacement Therapy:

  • In patients with documented hormonal imbalances such as low testosterone levels, hormone replacement therapy may be considered to improve libido and erectile function.

Psychological Counseling:

  • Addressing psychological factors such as stress, anxiety, depression, or relationship issues is essential in managing ED. Cognitive-behavioral therapy (CBT), sex therapy, or couples counseling may be beneficial in addressing these concerns.

Lifestyle Modifications:

  • Encouraging lifestyle modifications such as smoking cessation, weight management, regular exercise, and moderation of alcohol consumption can improve overall vascular health and may help alleviate ED symptoms.

Surgical Interventions:

  • In cases where other treatments have failed, surgical options such as penile implants may be considered as a last resort for ED management.


Understanding the nuanced relationship between rheumatological diseases and erectile dysfunction is crucial for comprehensive patient care, necessitating a multidisciplinary approach that addresses both the physical and emotional aspects of these interconnected health concerns.

Prof. Dr. Emin ÖZBEK


Istanbul- TURKIYE

Leave a Reply

Your email address will not be published.